Add BrightSurf on Google Email

Testosterone increases men's preference for status goods

A study published in Nature Communications found that testosterone increases men's preference for luxury products associated with high social status, rather than power or quality. The research team tested 243 male participants and found a causal link between testosterone levels and increased liking for status-enhancing goods.

SourceINSEAD·JournalNature Communications·DateJul 3, 2018

To share or not to share?

Research suggests that children's tendency to share is linked to their social status in the classroom, with those having few interaction partners tending to be more generous. Higher levels of prenatal testosterone are associated with a 'masculinisation effect' leading to less sharing.

SourceUniversity of Vienna·JournalScientific Reports·DateJun 15, 2018

Sex hormone levels alter heart disease risk in older women

A study of over 2,800 postmenopausal women found that a higher proportion of male to female sex hormones was associated with a significant increase in cardiovascular disease risk. The researchers suggest that having a more male-like hormone profile may affect heart disease risk independent of other risk factors.

SourceJohns Hopkins Medicine·JournalJournal of the American College of Cardiology·DateMay 29, 2018

Study finds that weight loss after obesity surgery can rapidly restore testosterone production and sex drive in morbidly obese men

A recent study found that rapid weight loss following sleeve gastrectomy can rapidly reverse obesity-related hypogonadism in morbidly obese men, restoring normal levels of testosterone and sex drive. The study showed a significant increase in testosterone levels after one month, while estradiol levels fell.

Medicine alone does not completely suppress testosterone levels among transgender women

A recent study published in Endocrine Practice found that only a quarter of transgender women could lower their testosterone levels within the female range using spironolactone and estrogen therapy. The researchers identified four groups with varying degrees of testosterone suppression, highlighting the need for further studies to unde...

SourceBoston University School of Medicine·JournalEndocrine Practice·DateFeb 20, 2018

Team traces masculinization in mice to estrogen receptor in inhibitory neurons

Researchers at Cold Spring Harbor Laboratory have identified the specific hormone receptors and brain regions responsible for masculinization in mice. The study found that estrogen receptor alpha is essential in inhibitory neurons for male sexual and aggressive behaviors to emerge, while deleting it had no impact on excitatory neurons.

SourceCold Spring Harbor Laboratory·JournalHormones and Behavior·DateJul 19, 2017

Testosterone treatments may increase cardiac risks

A new study published in JAMA suggests that testosterone treatments may increase the risk of heart disease in older men. The study found a significant increase in arterial plaque among men aged 65 and older who received testosterone replacement therapy for a year, with a 20% rise in total coronary and noncalcified plaque volumes.

SourceLA BioMed·JournalJAMA·DateFeb 21, 2017

Five studies in JAMA, JAMA Internal Medicine examine effect of testosterone treatment on various health outcomes in men

Studies published in JAMA and JAMA Internal Medicine found that testosterone treatment was associated with improved bone density and anemia in men with low testosterone. However, the studies also found no significant association between testosterone treatment and improved cognitive function or reduced risk of cardiovascular problems.

SourceJAMA Network·JournalJAMA·DateFeb 21, 2017

Testosterone therapy provides protection against cardiovascular disease in men with low testosterone

A new study found that long-term testosterone therapy improves vigor and vitality, while reducing the risk of death due to cardiovascular disease in men with hypogonadism. The research suggests that testosterone therapy is an effective approach for secondary prevention in hypogonadal men with a history of cardiovascular events.

SourceBoston University School of Medicine·JournalJournal of Cardiovascular Pharmacology and Therapeutics·DateFeb 13, 2017